Compare OneSpan Inc (OSPN) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
OneSpan Inc vs Stryker Corporation — how do they compare? OneSpan Inc trades at $18.22 (market cap $662.97M), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 160.2× OneSpan Inc's market cap, and OneSpan Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Stryker Corporation for 21 Days on average.
| OSPN | SYK | |
|---|---|---|
Market Cap | $662.97M | $106.24B |
Volume | 616,882 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $18.42 | $388.35 |
52-Week Low | $10.15 | $269.75 |
Typical Hold Time | 18 Days | 21 Days |
Enterprise Value | $632.05M | $117.70B |
Dividend Yield | 2.89% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OneSpan (OSPN) trades at $18.01, up 1.75% with strong technical momentum and consistent earnings beats. The stock shows bullish moving average signals while maintaining solid fundamentals including 27.76% net margins and attractive valuation at 10.16 P/E. Recent Q2 2026 results exceeded expectations with $0.30 EPS versus $0.231 estimate, supporting the positive analyst sentiment.
Outlook remains favorable given the unanimous analyst buy/hold consensus and recent product innovation with DigipassONE launch. Key risks include declining cash flow trends and competitive pressures in the authentication technology space. The stock's current valuation and earnings momentum provide upside potential, though investors should monitor execution on subscription revenue growth.
Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.
SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
